The serum metabolite response to diet intervention with probiotic acidified milk in irritable bowel syndrome patients is indistinguishable from that of non-probiotic acidified milk by 1H NMR-based metabonomic analysis

Nutrients

Volumn 2, Issue 11, 2010, Pages 1141-1155

  Pedersen, Simon M M ^a,b,f   Nielsen, Niels Chr ^b   Andersen, Henrik J ^c   Olsson, Johan ^d   Simrén, Magnus ^e   Öhman, Lena ^e   Svensson, Ulla ^c   Malmendal, Anders ^b   Berthgam, Hanne C ^a  

^a DANISH INSTITUTE OF AGRICULTURAL SCIENCES   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c Arla Foods   (Denmark)

^d KPL Good Food Practice AB   (Sweden)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

1H NMR spectroscopy; Acidified milk products; Irritable bowel syndrome; Lactate; Metabonomics; Multivariate data analysis; Probiotics

Indexed keywords

3 HYDROXYBUTYRIC ACID; LACTIC ACID;

ADULT; AGED; ARTICLE; BIFIDOBACTERIUM ANIMALIS; BLOOD ANALYSIS; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; FEMALE; FERMENTED PRODUCT; HUMAN; IRRITABLE COLON; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS PARACASEI; MAJOR CLINICAL STUDY; MALE; METABOLOMICS; MILK; OUTCOME ASSESSMENT; PROBIOTIC ACIDIFIED MILK PRODUCT; PROTON NUCLEAR MAGNETIC RESONANCE; STREPTOCOCCUS THERMOPHILUS; SYMPTOM; THERAPY EFFECT; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 79952053264     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu2111141     Document Type: Article

References (42)

1. Drossman, D.A.; Camilleri, M.; Mayer, E.A.; Whitehead, W.E. AGA technical review on irritable bowel syndrome. Gastroenterology 2002, 123 (6), 2108-2131.
2. Akehurst, R.; Kaltenthaler, E. Treatment of irritable bowel syndrome: A review of randomised controlled trials. Gut 2001, 48 (2), 272-282.
3. Foxx-Orenstein, A. IBS-review and what's new. MedGenMed 2006, 8 (3), 20.
4. Kim, H.J.; Camilleri, M.; McKinzie, S.; Lempke, M.B.; Burton, D.D.; Thomforde, G.M.; Zinsmeister, A.R. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment. Pharmacol. Ther. 2003, 17 (7), 895-904.
5. Gosselink, M.P.; Schouten, W.R.; van Lieshout, L.M.; Hop, W.C.; Laman, J.D.; Ruseler-van Embden, J.G. Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG. Dis. Colon Rectum 2004, 47 (6), 876-884.
6. Gionchetti, P.; Rizzello, F.; Helwig, U.; Venturi, A.; Lammers, K.M.; Brigidi, P.; Vitali, B.; Poggioli, G.; Miglioli, M.; Campieri, M. Prophylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo-controlled trial. Gastroenterology 2003, 124 (5), 1202-1209.
7. Niedzielin, K.; Kordecki, H.; Birkenfeld, B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur. J. Gastroenterol. Hepatol. 2001, 13 (10), 1143-1147.
8. Kajander, K.; Hatakka, K.; Poussa, T.; Farkkila, M.; Korpela, R. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: A controlled 6-month intervention. Aliment. Pharmacol. Ther. 2005, 22 (5), 387-394.
9. Kajander, K.; Myllyluoma, E.; Rajilic-Stojanovic, M.; Kyronpalo, S.S.; Rasmussen, M.; Jarvenpaa, S.S.; Zoetendal, E.G.; de Vos, W.M.; Vapaatalo, H.; Korpela, R. Clinical trial: Multispecies probiotic supplementation alleviates the symptoms of IBS and stabilises intestinal microbiota. Aliment. Pharmacol. Ther. 2007, 27 (1), 48-57.
10. Simren, M.; Ohman, L.; Olsson, J.; Svensson, U.; Ohlson, K.; Posserud, I.; Strid, H. Clinical trial: The effect of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome (IBS)-a randomized, double-blind, controlled study. Aliment. Pharmacol. Ther. 2010, 31 (2), 218-227.
11. Guyonnet, D.; Chassany, O.; Ducrotte, P.; Picard, C.; Mouret, M.; Mercier, C.H.; Matuchansky, C. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Aliment. Pharmacol. Ther. 2007, 26 (3), 475-486.
12. Enck, P.; Klosterhalfen, S. The placebo response in functional bowel disorders: Perspectives and putative mechanisms. Neurogastroenterol. Motil. 2005, 17 (3), 325-331.
13. Pitz, M.; Cheang, M.; Bernstein, C.N. Defining the predictors of the placebo response in irritable bowel syndrome. Clin. Gastroenterol. Hepatol. 2005, 3 (3), 237-247.
14. Weljie, A.M.; Dowlatabadi, R.; Miller, B.J.; Vogel, H.J.; Jirik, F.R. An inflammatory arthritis-associated metabolite biomarker pattern revealed by 1H NMR spectroscopy. J. Proteome Res. 2007, 6 (9), 3456-3464.
15. Slupsky, C.M.; Rankin, K.N.; Wagner, J.; Fu, H.; Chang, D.; Weljie, A.M.; Saude, E.J.; Lix, B.; Adamko, D.J.; Shah, S.; Greiner, R.; Sykes, B.D.; Marrie, T.J. Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Anal. Chem. 2007, 79 (18), 6995-7004.
16. Holmes, E.; Loo, R.L.; Stamler, J.; Bictash, M.; Yap, I.K.; Chan, Q.; Ebbels, T.; De Iorio, M.; Brown, I.J.; Veselkov, K.A.; Daviglus, M.L.; Kesteloot, H.; Ueshima, H.; Zhao, L.; Nicholson, J.K.; Elliott, P. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 2008, 453 (7193), 396-400.
17. Lenz, E.M.; Wilson, I.D. Analytical strategies in metabonomics. J. Proteome Res. 2007, 6 (2), 443-458.
18. Ersryd, A.; Posserud, I.; Abrahamsson, H.; Simren, M. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III. Aliment. Pharmacol. Ther. 2007, 26 (6), 953-961.
19. Francis, C.Y.; Morris, J.; Whorwell, P.J. The irritable bowel severity scoring system: A simple method of monitoring irritable bowel syndrome and its progress. Aliment. Pharmacol. Ther. 1997, 11 (2), 395-402.
20. Bax, A.; Davis, D.G. MLEV-17-Based Two-Dimensional Homonuclear Magnetization Transfer Spectroscopy. J. Magn. Reson. 1985, 65, 355-360.
21. Trygg, J.; Wold, S. O2-PLS, a two-block (X-Y) latent variable regression (LVR) method with an integral OSC filter. J. Chemom. 2003, 17 (1), 53-64.
22. Nicholson, J.K.; Foxall, P.J.; Spraul, M.; Farrant, R.D.; Lindon, J.C. 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal. Chem. 1995, 67 (5), 793-811.
23. Fan, M. Metabolite profiling by one- and two-dimensional NMR analysis of complex mixtures. Prog. Nucl. Magn. Reson. Spectrosc. 1996, 28, 161-219.
24. Lindon, J.C. NMR Spectroscopy on Biofluids. Annu. Rep. NMR Spectrosc. 1999, 38, 1-88.
25. Tugnoli, V.; Mucci, A.; Schenetti, L.; Calabrese, C.; Di Febo, G.; Rossi, M.C.; Tosi, M.R. Molecular characterization of human gastric mucosa by HR-MAS magnetic resonance spectroscopy. Int. J. Mol. Med. 2004, 14 (6), 1065-1071.
26. Wishart, D.S.; Tzur, D.; Knox, C.; Eisner, R.; Guo, A.C.; Young, N.; Cheng, D.; Jewell, K.; Arndt, D.; Sawhney, S.; et al. HMDB: The Human Metabolome Database. Nucleic Acids Res. 2007, 35, D521-D526.
27. Connolly, E.; Lönnerdal, B. D(-)-Lactic acid producing bacteria-Safety to use in infant formulas. Nutrafoods 2004, 3 (3), 37-49.
28. Ljungh, A.; Lan, J.; Yanagisawa, N. Isolation, selection and characteristics of Lactobacillus paracasei subsp. paracasei F19. Microb. Ecol. Health Dis. 2002, 14 (1), 4-6.
29. Bergman, B.C.; Wolfel, E.E.; Butterfield, G.E.; Lopaschuk, G.D.; Casazza, G.A.; Horning, M.A.; Brooks, G.A. Active muscle and whole body lactate kinetics after endurance training in men. J. Appl. Physiol. 1999, 87 (5), 1684-1696.
30. Van Hall, G.; Calbet, J.A.; Sondergaard, H.; Saltin, B. Similar carbohydrate but enhanced lactate utilization during exercise after 9 wk of acclimatization to 5,620 m. Am. J. Physiol. Endocrinol. Metab. 2002, 283 (6), E1203-E1213.
31. Gladden, L.B. Lactate metabolism: A new paradigm for the third millennium. J. Physiol. 2004, 558 (1), 5-30.
32. Stanley, W.C.; Gertz, E.W.; Wisneski, J.A.; Neese, R.A.; Morris, D.L.; Brooks, G.A. Lactate extraction during net lactate release in legs of humans during exercise. J. Appl. Physiol. 1986, 60 (4), 1116-1120.
33. Kreisberg, R.A. Lactate homeostasis and lactic acidosis. Ann. Intern. Med. 1980, 92 (2), 227-237.
34. Eldridge, F.L.; T'So, L.; Chang, H. Relationship between turnover rate and blood concentration of lactate in normal dogs. J. Appl. Physiol. 1974, 37 (3), 316-320.
35. Lloyd, S.; Brocks, C.; Chatham, J.C. Differential modulation of glucose, lactate, and pyruvate oxidation by insulin and dichloroacetate in the rat heart. Am. J. Physiol. Heart Circ. Physiol. 2003, 285 (1), H163-H172.
36. Kelleher, J.K. Gluconeogenesis from labeled carbon: Estimating isotope dilution. Am. J. Physiol. 1986, 250 (3), E296-E305.
37. Burgess, S.C.; Hausler, N.; Merritt, M.; Jeffrey, F.M.; Storey, C.; Milde, A.; Koshy, S.; Lindner, J.; Magnuson, M.A.; Malloy, C.R.; Sherry, A.D. Impaired tricarboxylic acid cycle activity in mouse livers lacking cytosolic phosphoenolpyruvate carboxykinase. J. Biol. Chem. 2004, 279 (47), 48941-48949.
38. Spiller, R.C.; Jenkins, D.; Thornley, J.P.; Hebden, J.M.; Wright, T.; Skinner, M.; Neal, K.R. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000, 47 (6), 804-811.
39. Marshall, J.K.; Thabane, M.; Garg, A.X.; Clark, W.; Meddings, J.; Collins, S.M. Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario. Aliment. Pharmacol. Ther. 2004, 20 (11-12), 1317-1322.
40. Dunlop, S.P.; Hebden, J.; Campbell, E.; Naesdal, J.; Olbe, L.; Perkins, A.C.; Spiller, R.C. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am. J. Gastroenterol. 2006, 101 (6), 1288-1294.
41. Gecse, K.; Roka, R.; Ferrier, L.; Leveque, M.; Eutamene, H.; Cartier, C.; Ait-Belgnaoui, A.; Rosztoczy, A.; Izbeki, F.; Fioramonti, J.; Wittmann, T.; Bueno, L. Increased faecal serine protease activity in diarrhoeic IBS patients: A colonic lumenal factor impairing colonic permeability and sensitivity. Gut 2008, 57 (5), 591-599.
42. Piche, T.; Barbara, G.; Aubert, P.; Bruley des Varannes, S.; Dainese, R.; Nano, J.L.; Cremon, C.; Stanghellini, V.; De Giorgio, R.; Galmiche, J.P.; Neunlist, M. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: Involvement of soluble mediators. Gut 2009, 58 (2), 196-201.